Usability of the Adapted Rower for People With Spinal Cord Injury
- Disease/Condition
- Spinal Cord Injuries
- Drug/Device/Intervention
- Adaptive Rowing Exercise
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- University of South Carolina
- Location
- Columbia, United States of America
- Phase
- N/A
- Start date
- Jul 24, 2023
- End date
- Jun 01, 2024
- Enrollment
- 15 participants
Heart Rate, (beats per minute), mean and range at rest, mean and range during steady state portion, mean and range during interval portion,Rate of Perceived Exertion (RPE)-Borg 6-20 Scale,Pain Scale (0-10 visual analog scale, higher means worse pain ) and body location of pain verbalized by participant and recorded by study personnel,Physical Activity Enjoyment Scale (Short); average score (1-5),System Useability Scale, average score (1-5),Pain Scale (0-10 visual analog scale, higher means worse pain ) and body location of pain
The goal of this clinical trial is to examine usability of a locally built adaptive rower for
 people with spinal cord injury using an established and tested design.
 
 The main questions it aims to answer are:
 
 1. What exercise intensity of activity do users achieve on the rower for steady state and
 interval rowing plans?
 
 2. What assistance is required for setup and usage of the adaptive rower?
 
 3. What do users think about the ease of use and what is their satisfaction with the
 adaptive rower?
 
 Participants will complete a one-time exercise session with two adaptive rower bouts (10-15
 minutes each) with a rest period in between.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05959837
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05959837 through Pure Global AI's free database. This phase not specified trial is sponsored by University of South Carolina and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 15 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.